Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Kun Cai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0070-5954; OpenAlex author ID A5060438848. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2022: 6 papers · 2023: none · 2024: 2 papers · 2025: none · 2026: 2 papers

Papers 10

  1. FGD5 regulates PGK1 ubiquitination to synergize with 2-deoxy-D-glucose in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-026-03943-1↗
  2. Targeting PSMD14 increases chemotherapeutic sensitivity to gemcitabine by inhibiting the WNT/β-catenin pathway and glycolysis in pancreatic cancer. Co-author DOI 10.1038/s41419-026-08958-w↗
  3. TRIM59/RBPJ positive feedback circuit confers gemcitabine resistance in pancreatic cancer by activating the Notch signaling pathway. Co-author DOI 10.1038/s41419-024-07324-y↗
  4. CD105+CAF-derived exosomes CircAMPK1 promotes pancreatic cancer progression by activating autophagy. Co-author DOI 10.1186/s40164-024-00533-3↗
  5. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis. Co-author DOI 10.1038/s41419-022-04669-0↗
  6. Autophagy-associated circRNA circATG7 facilitates autophagy and promotes pancreatic cancer progression. First author DOI 10.1038/s41419-022-04677-0↗
  7. FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis. Co-author DOI 10.1038/s41419-022-05213-w↗
  8. RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling path… First author DOI 10.1038/s41419-022-05379-3↗
  9. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma. Co-author DOI 10.1186/s12885-022-10128-y↗
  10. MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway. Co-author DOI 10.1186/s12967-022-03749-1↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shiyu Chen · 7 shared papers, 2022–2026 · strength 1.57
  2. Zhiwei He · 7 shared papers, 2022–2026 · strength 1.37
  3. Cheng-Yi Sun · 4 shared papers, 2022–2026 · strength 0.81
  4. Dijie Zheng · 4 shared papers, 2022 · strength 0.68
  5. Xiaowu Li · 2 shared papers, 2022–2024 · strength 0.44
  6. Lin Li · 2 shared papers, 2022 · strength 0.36
  7. Chao Yu · 2 shared papers, 2022 · strength 0.35
  8. Yanqing Liu · 2 shared papers, 2022 · strength 0.32
  9. Wenting Song · 1 shared paper, 2026 · strength 0.32
  10. Tianbao Wang · 1 shared paper, 2026 · strength 0.29
  11. Hui Liu · 1 shared paper, 2024 · strength 0.26
  12. Zhiwei He · 1 shared paper, 2024 · strength 0.26
  13. Xiushen Li · 1 shared paper, 2024 · strength 0.26
  14. Xundi Xu · 1 shared paper, 2024 · strength 0.22
  15. Yan Zhang · 1 shared paper, 2024 · strength 0.22
  16. Zhirui Zeng · 1 shared paper, 2022 · strength 0.19
  17. Wenpeng Cao · 1 shared paper, 2022 · strength 0.19
  18. Shan Lei · 1 shared paper, 2022 · strength 0.19
  19. Chao Yu · 1 shared paper, 2022 · strength 0.17
  20. Chao Yu · 1 shared paper, 2022 · strength 0.17
  21. Yufei Zhu · 1 shared paper, 2022 · strength 0.17
  22. Lin Li · 1 shared paper, 2022 · strength 0.16
  23. Lin Li · 1 shared paper, 2022 · strength 0.15
  24. Chao Yu · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.